| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY |
|---|---|---|---|---|
| Revenue | – | – | – | – |
| Cost of Revenue | – | – | – | – |
| Gross Profit | – | – | – | – |
| Operating Expenses | – | – | – | – |
| R&D | $11.23M | $3.06M | $2.71M | $1.90M |
| SG&A | $120.10M | $12.73M | $16.57M | $2.72M |
| Operating Income | -$146.29M | -$27.86M | -$36.74M | -$5.19M |
| Interest Expense | $40.70M | $13.49M | $7.89M | $1.13M |
| Tax Expense | – | – | – | – |
| Net Income | -$174.59M | -$35.40M | -$20.99M | -$6.18M |
| EPS (basic) | -0.8200 | -248.0000 | – | -0.0400 |
| EPS (diluted) | -0.8200 | -248.0000 | -7.8200 | – |
| Shares (diluted) | $206.85K | $125.33K | $2.68K | – |